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Background: Family members of patients with end stage renal disease were reported to have an increased
prevalence of chronic kidney disease (CKD). However, studies differentiated genetic and non-genetic family
members are limited. We sought to investigate the prevalence of CKD among fist-degree relatives and spouses of
dialysis patients in China.
Methods: Seventeen dialysis facilities from 4 cities of China including 1062 first-degree relatives and 450 spouses of
dialysis patients were enrolled. Sex- and age- matched controls were randomly selected from a representative sample
of general population in Beijing. CKD was defined as decreased estimated glomerular (eGFR < 60 mL/min/1.73 m2) or
albuminuria.
Results: The prevalence of eGFR less than 60 mL/min/1.73 m2, albuminuria and the overall prevalence of CKD in
dialysis spouses were compared with their counterpart controls, which was 3.8% vs. 7.8% (P < 0.01), 16.8% vs. 14.6%
(P = 0.29) and 18.4% vs. 19.8% (P = 0.61), respectively. The prevalence of eGFR less than 60 mL/min/1.73 m2,
albuminuria and the overall prevalence of CKD in dialysis relatives were also compared with their counterpart controls,
which was 1.5% vs. 2.4% (P = 0.12), 14.4% vs. 8.4% (P < 0.01) and 14.6% vs. 10.5% (P < 0.01), respectively. Multivariable
Logistic regression analysis indicated that being spouses of dialysis patients is negatively associated with presence of
low eGFR, and being relatives of dialysis patients is positively associated with presence of albuminuria.
Conclusions: The association between being family members of dialysis patients and presence of CKD is different
between first-degree relatives and spouses. The underlying mechanisms deserve further investigation.
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Chronic kidney disease (CKD) is a global public health
problem [1,2], and it affects 10-16% of the adult popula-
tion in Asia, Australia, Europe and the United States [3,4].
A recent national survey in China [3] indicates that the
prevalence of CKD in China is 10.8%, and the number of
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reproduction in any medium, provided the orbeen associated with high morbidity and mortality [5],
hence it is important to launch programs aiming at redu-
cing the burden of CKD. It is reported that screening for
proteinuria among high-risk population is cost-effective
[6]. However, who constitute high-risk population for
CKD remains to be answered.
Recent studies revealed that family members of patients
with end stage renal disease (ESRD) have an increased
prevalence of CKD [7-12]. Differences in ethnicities, life-
styles and screening methods may cause high variability
in results [13,14]. Furthermore, some studies did not dif-
ferentiate the genetic and non-genetic family mem-
bers of patients with ESRD. A recent study from Taiwantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients were found to have high prevalence of CKD [15].
The limited number of participants and the limited repre-
sentativeness of controls constraint the power of that study.
The present study was conducted to investigate the preva-
lence of CKD among the first-degree relatives and spouses
of dialysis patients, and to compare that with controls from
a representative sample of general population in Beijing.
Methods
Study population
Seventeen dialysis facilities from 4 cities of China were
enrolled (12 in Beijing, 3 in Tianjin, 1 in Dalian and 1 in
Shijiazhuang). ESRD Patients with inherited kidney dis-
ease, such as autosomal dominant polycystic kidney dis-
ease or Alport’s syndrome were excluded for this study.
All family members, including first-degree relatives (in-
cluding parent, sibling and child) and spouses of these
patients were invited to participate in the study from
October 2006 to August 2007. Altogether 1642 family
members of ESRD patients participated in this study on
a voluntary basis. Among them, 130 members who
didn’t have either complete questionnaire or complete
lab results were excluded. Finally, 1062 relatives and 450
spouses from 715 hemodialysis and 127 peritoneal dialy-
sis families were eligible for present analysis. The ethics
committee of Peking University First Hospital approved
the study, which covers all participating institutions. All
participants gave written informed consent before data
collection.
Controls were selected from a representative sample of
the general population of adults in Beijing, which is des-
cribed in details elsewhere [16].
Screening protocol and assessment criteria
Data were collected in examination centers at local health
stations. All subjects completed a questionnaire docu-
menting their sociodemographic status (e.g., age, sex, and
educational level), health status (renal disease, diabetes
mellitus, or hypertension), history of nephrotoxic medica-
tions (non-steroids anti-inflammatory drugs, [NSAIDS] or
Chinese herbs containing aristolochic acid, [AA]), lifestyle
behaviors (e.g., smoking), and the primary causes of renal
failure of dialysis patients (glomerular disease, hyperten-
sion, diabetes, interstitial nephritis, and ‘all other’ causes).
Anthropometric measurements were obtained. Indica-
tors of kidney damage and possible risk factors then were
examined. All blood samples and urinary samples were
tested in the central laboratory of Beijing University First
Hospital.
Definitions of CKD
Albumin and creatinine were measured from a fresh
morning spot urine sample or morning urine samplestored at 4°C for less than 1 week. Albuminuria was
measured using immunoturbidimetic methods (Audit
Diagnostics, Cork, Ireland). Urinary creatinine was mea-
sured by means of Jaffe’s kinetic method on a Hitachi 7170
autoanalyzer (Hitachi, Tokyo, Japan). Urinary albumin-
creatinine ratio (ACR; milligrams per gram) was calcu-
lated. Patients with ACR determinations that ranged from
17 to 250 mg/g (1.9 to 28.3 mg/mmol) for males and 25 to
355 mg/g (2.8 to 40.2 mg/mmol) for females were classi-
fied as having microalbuminuria, and participants with
ACR values greater than the microalbuminuria range were
classified as having macroalbuminuria. Albuminuria was
defined as the presence of either microalbuminuria or
macroalbuminuria. Women during menstruation were
excluded from analyses for albuminuria.
Blood was collected by venipuncture after an overnight
fast of at least 10 hours. Serum creatinine was measured
by the same methods as was urinary creatinine. eGFR was
calculated with an equation developed by modifying the
Modification of Diet in Renal Disease (MDRD) equation
based on data from Chinese CKD patients [17]. And
decreased kidney function was defined as eGFR < 60 ml/
min/1.73 m2 (1.00 ml/s/1.73 m2):
eGFR ml=min=1:73m2
  ¼ 175  Scr1:234
 age0:179
 if female;  0:79ð Þ
where Scr is serum creatinine concentration (in mg/dL)
and age in years.
The CKD was defined as decreased kidney function or
albuminuria based on the classification system established
by the National Kidney Foundation Kidney Disease Out-
comes Quality Initiative (K/DOQI) [18].
Definition of other conditions
Blood pressure was measured by sphygmomanometer,
three times at 1 minute intervals. The mean of the three
readings was calculated, unless the difference between
readings was greater than 10 mmHg, in which case the
mean of the two closet of the three measurements was
used. Hypertension was defined as systolic blood pres-
sure of 140 mmHg or greater or diastolic blood pressure
of 90 mmHg or greater or use of antihypertensive medi-
cations in past 2 weeks irrespective of blood pressure, or
any self-reported history of hypertension. Fasting blood glu-
cose was measured enzymatically by means of a glucose
oxidase method using the Hitachi 7170 autoanalyzer. Dia-
betes was defined as fasting plasma glucose of 7.0 mmol/L
or more, by hypoglycaemic agents despite fasting plasma
glucose, or any self-reported history of diabetes.
Serum total cholesterol, low-density lipoprotein cho-
lesterol, high-density lipoprotein cholesterol, and trigly-
Table 1 Comparison of demographic and clinical







Age (y) 57.9 ± 11.7 57.4 ± 12.6 0.51
Male (%) 181 (40.2) 362 (40.2) 1.0
Education (≥High School, %) 260 (57.8) 419 (46.7) <0.001
Hypertension (%) 197 (43.9) 500 (55.7) <0.001
Diabetes (%) 71 (15.8) 125 (14.0) 0.41
Overweight (%) 290 (64.7) 584 (64.9) 0.95
Nephrotoxic medications (%) 36 (8.0) 34 (3.9) <0.01
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available reagents using a Hitachi 7170 autoanalyzer.
The body mass index (BMI) was calculated as weight (in
kilograms) divided by height squared (in meters squared).
Overweight is defined as BMI greater than 24 kg/m2.
BMI = weight (kg)/height (m2) × 100%. Dyslipidemia was
defined as present if total cholesterol was ≥ 5.72 mmol/L
(220 mg/dL), or if low density lipoprotein (LDL) was ≥
3.64 mmol/L (140 mg/dL), or triglyceride was ≥
1.70 mmol/L (150 mg/dL) or high density lipoprotein
(HDL) was < 0.91 mmol/L (35 mg/dL). Hyperuricaemia
was defined as serum uric acid > 422 μmol/L for males
and > 363 μmol/L for females.Chronic respiratory tract infection (%) 106 (23.6) 158 (17.6) 0.01
Dyslipidemia (%) 231 (51.3) 378 (42.0) <0.01
eGFR (mL/min/1.73 m2) 86.9 ± 16.8 83.7 ± 18.1 <0.01
Low eGFR (%) <60 (mL/min/1.73 m2) 17 (3.8) 70 (7.8) <0.01
Albuminuria (%) 74 (16.8) 131 (14.6) 0.29
CKD (%) 83 (18.4) 178 (19.8) 0.61
Note: Data expressed as mean ± standard deviation or number (percentage);
Overweight was defined as body mass index >24 kg/m2; Dyslipidemia was
defined as present if total cholesterol was ≥ 5.72 mmol/L (220 mg/dL), or if low
density lipoprotein was ≥ 3.64 mmol/L (140 mg/dL), or triglyceride was ≥
1.70 mmol/L (150 mg/dL) or high density lipoprotein was < 0.91 mmol/L
(35 mg/dL); Albuminuria was defined as urinary albumin-creatinine ratio ≥
17 mg/g (1.9 mg/mmoL) for males and 25 mg/g (2.8 mg/mmoL) for females;
CKD was defined as decreased kidney function (<60 mL/min/1.73 m2) or
albuminuria.
Abbreviations: eGFR, estimated glomerular filtration rate; CKD, chronic kidney
disease.Statistics analysis
All analyses and calculations were performed by SPSS stat-
istical package, version 16.0 (SPSS Inc., Chicago, IL, USA).
Controls were selected from the cross-sectional survey of
CKD in a representative sample of the general adults in
Beijing [16]. Sample sizes of each age-stratified group of
≤ 30, 31–40, 41–50, 51–60, and > 60 years were 1814, 2816,
4206, 3002, and 2097 participants, respectively. In selecting
controls for spouses, 900 sex- and age-stratified matched
participants were randomly selected as controls. 2124 sex-
and age-stratified matched participants were randomly
selected as controls for relatives.
Data were presented as the mean ± standard deviation
for continuous variables and as proportions for categorical
variables. Descriptive analysis were used to characterize
the participant population by sociodemographic data (eg.
age, sex and education status) and health status (eg. hyper-
tension and diabetes). Differences in variables between the
two groups were analyzed using chi-square statistics for
categorical variables or independent t-test for continuous
variables. The unadjusted odds ratios (OR) between family
members of dialysis patients and indicators of kidney
damage were determined by univariate Logistic regression
analysis. McNemar’s test was used to test univariate asso-
ciations. A multivariate Logistic regression analysis was
then performed to adjust for confoundings including age,
gender, diabetes, hypertension, nephrotoxic medications,
dyslipidemia, overweight, and chronic respiratory tract in-
fection. Odds ratio (OR) was calculated and 95% confi-
dence interval (CI) was provided. A P value of 0.05 or less
was considered to be statistically significant.
Results
Spouses of dialysis patients
Characteristics of spouses and matched controls are listed
in Table 1. eGFR was significantly higher in dialysis spouses
than controls (86.9 ± 16.8 vs. 83.7 ± 18.1 mL/min/1.73 m2,
P < 0.01). A significantly lower prevalence of low eGFR was
found in dialysis spouses compared with controls (3.8% vs.7.8%, P < 0.01). There were no differences in the prevalence
of albuminuria (16.8% vs. 14.6%, P = 0.29) and CKD (18.4%
vs. 19.8%, P = 0.61) between these two groups.
Among spouses, the prevalence of nephrotoxic medica-
tions use was higher and the prevalence of hypertension
was lower compared with that of controls. There were no
differences in prevalence of diabetes and overweight bet-
ween these two groups. After adjusting for potential con-
founders, being spouses of dialysis patients was negatively
associated with presence of decreased eGFR, with an OR of
0.50 (95% CI 0.28–0.88; Table 2).First-degree relatives of dialysis patients
Characteristics of relatives and matched controls are
listed in Table 3. A significantly higher prevalence of al-
buminuria (14.4% vs. 8.4%, P < 0.001) was found in rela-
tives compared with controls. There was no difference
in the prevalence of reduced eGFR between two groups
(1.5% vs. 2.4%, P = 0.12).
The prevalence of diabetes and nephrotoxic medication
use were higher among relatives compared with those of
controls, while the prevalence of hypertension was lower
among relatives compared with that of controls. After
Table 2 Unadjusted and adjusted odds ratio for






Unadjusted OR (95% CI) 1.19 (0.87 – 1.62) 1.83 (1.45 – 2.31)
Age- and sex-adjusted OR
(95% CI)
1.18 (0.86 – 1.62) 1.84 (1.45 – 2.32)
Multivariable adjusted OR
(95% CI)
1.28 (0.92 – 1.77)‡ 2.02 (1.57 – 2.59)§
Decreased eGFR
Unadjusted OR (95% CI) 0.47 (0.27 – 0.80) 0.63 (0.36 – 1.11)
Age- and sex-adjusted OR
(95% CI)
0.46 (0.27 – 0.80) 0.64 (0.36 – 1.13)
Multivariable adjusted OR
(95% CI)
0.50 (0.28 – 0.88)§ 0.68 (0.38 – 1.21) ‡
CKD
Unadjusted OR (95% CI) 0.92 (0.69 – 1.23) 1.46 (1.17 – 1.82)
Age- and sex-adjusted OR
(95% CI)
0.91 (0.67 – 1.22) 1.47 (1.17 – 1.83)
Multivariable adjusted OR
(95% CI)
0.98 (0.72 – 1.33) ‡ 1.58 (1.25 – 2.0)§
Abbreviations: CKD, chronic kidney disease; OR, odds ratio; estimated
glomerular filtration rate; CI, confidence interval.
* Pooled database including data of spouses and their counterpart controls.
† Pooled database including data of relatives and their counterpart controls.
‡ORs were adjusted for age, gender, hypertension, diabetes.
§ORs were adjusted for age, gender, hypertension, diabetes, nephrotoxic
medications, chronic respiratory tract infection, overweight, dyslipidemia,
education (≥high school).
Table 3 Comparison of demographic and clinical







Age (y) 44.0 ± 12.1 43.7 ± 12.3 0.61
Male (%) 401 (37.8) 802 (37.8) 1.0
Education (≥High School, %) 810 (76.3) 1393 (65.8) <0.001
Hypertension (%) 278 (26.3) 721 (34.0) <0.001
Diabetes (%) 109 (10.3) 162 (7.7) 0.02
Overweight (%) 588 (55.6) 1182 (55.7) 1.0
Nephrotoxic medications (%) 67 (6.4) 51 (2.4) <0.001
Chronic respiratory tract infection (%) 178 (16.9) 300 (14.1) 0.05
Dyslipidemia (%) 480 (45.2) 673 (31.7) <0.001
eGFR (mL/min/1.73 m2) 94.0 ± 16.9 92.4 ± 18.9 0.03
Low eGFR (%) <60 (mL/min/1.73 m2) 16 (1.5) 50 (2.4) 0.12
Albuminuria (%) 149 (14.4) 178 (8.4) <0.001
CKD (%) 155 (14.6) 221 (10.5) <0.01
Note: Data expressed as mean ± standard deviation or number (percentage);
Overweight was defined as body mass index >24 kg/m2; Dyslipidemia was defined
as present if total cholesterol was≥ 5.72 mmol/L (220 mg/dL), or if low density
lipoprotein was ≥ 3.64 mmol/L (140 mg/dL), or triglyceride was≥ 1.70 mmol/L
(150 mg/dL) or high density lipoprotein was < 0.91 mmol/L (35 mg/dL); Albuminuria
was defined as urinary albumin-creatinine ratio ≥ 17 mg/g (1.9 mg/mmoL) for males
and 25 mg/g (2.8 mg/mmoL) for females; CKD was defined as decreased kidney
function (<60 mL/min/1.73 m2) or albuminuria.
Abbreviations: eGFR, estimated glomerular filtration rate; CKD, chronic kidney
disease.
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lysis patients was positively associated with presence of al-
buminuria, with an OR of 2.02 (95%CI 1.57–2.59; Table 2).
Discussion
Our study revealed a higher prevalence of albuminuria
among first-degree relatives of dialysis patients, and the
positive association is independent of various potential
confounders. Furthermore, we observed a lower prevalence
of decreased renal function among spouses of dialysis
patients compared with controls. A major strength of our
study is the large sample size and the representativeness of
controls.
The high prevalence of CKD among first-degree rela-
tives of dialysis patients in our study is consistent with
previous studies [19,20]. Compared with previous scree-
ning programs for high-risk populations, the prevalence of
albuminuria in relatives of dialysis patients (14.4%) in this
study was lower than that from the Kidney Early Evalua-
tion Program (KEEP) study (29%) [21], but similar to that
from Tsai’s study (10.7%) [15]. This figure was higher than
the observed rate of albuminuria in a general population-
based screening program in China (9.4%)3 and in Europe
and the United States (5.9% – 7.4%) [22,23]. One possi-
ble explanations might be familial clustering of metabolicdisorders, such as hypertension and diabetes, which are
known risk factors of albuminuria. Previous studies sug-
gested that, of these renal risk factors, hypertension and
diabetes mellitus are multifactorial disease under the in-
fluence of both genetic traits and environmental factors
[10,24]. Environmental factors, such as low socioeconomic
status and lifestyle of inactivity and smoking, also should
be considered as potential contributing for CKD [25,26].
However, in our analyses, after adjusting for potential con-
founders, the positive association between being relatives of
dialysis patients and albuminuria still exist, indicating that
there might be genetic susceptibility of CKD for relatives.
Genetic traits may contribute to the development of
CKD in relatives of dialysis patients. It is well known that
familial focal segmental glomerulosclerosis (FSGS) is a sig-
nificant and growing cause of CKD. Given the progress in
understanding the biology and pathology of podocyte, mu-
tation of associated genes, such as ACTN4, TRPC6 and
NPHS2, contribute to the damage of podocyte and podo-
cyte dysfunction [27,28]. The latter was associated to the
development of proteinuria and FSGS [29]. These genes
were recognized to be the genetic basis of FSGS. Mean-
while, more related genes or chromosomal regions were
identified in diabetic (3q, 18q22.3-23), non-diabetic nephro-
pathy (chromosome 10), systemic lupus erythematosus and
familial IgA nephropathy (6q22-23) [30-32].
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nongenetic controls for studying the family clustering of
CKD [11]. Spousal concordance of health risks and
behaviors such as cardiovascular disease, hypertension,
metabolic syndrome and high fasting glucose levels has
been observed in many disease [33-35]. In this study, we
also found higher rates of some health risks in dialysis
spouses compared with controls, such as dyslipidemia
and use of nephrotoxic medications. However, this study
demonstrated a significantly lower prevalence of low
eGFR, but no differences in the prevalence of albumi-
nuria and CKD in dialysis spouses compared with con-
trols. Meanwhile, in our analyses, after adjusting for
potential confounders, the negative association between
being spouses of dialysis patients and low eGFR still
exist. These results were enhanced by the sufficient
number of participants from multicentric facilities and
the ample representativeness of sex- and age- matched
controls, which were randomly selected on a ratio of 2:1
from a representative sample of the general population
of adults in Beijing [16]. The exact reason was unknown.
We assumed that for being spouses of dialysis patients,
perceived and objective CKD knowledge are likely to
impact risk-modifying behavior in different ways. Multi-
component structured empowerment intervention is ef-
fective in pre-dialysis CKD patients and may lead to a
delay in the progression of kidney disease [36-40].
Our study has limitations that deserve mention.
Firstly, it was implemented on a voluntary bias within
the dialysis units. Additionally, ESRD patients who didn’t
start dialysis treatment were not included in present
study. There were kinds of selecting bias in the study
which limited the extension of the results from this
study. Secondly, urine and blood results were based on a
single measurement. It should be noticed that it might
overestimate the prevalence of albuminuria based on
one measurement. Finally, a cross-sectional study design
has several inherent weaknesses, such as lack of long-
term observation for outcome and difficulty interpreting
the association of exposure with outcome.Conclusions
In conclusion, the association between being family mem-
bers of dialysis patients and presence of CKD is different
between first-degree relatives and spouses. Genetic sus-
ceptibility may account for the phenomenon of family
clustering of CKD. However, non-genetic environmental
factors also should be considered as potential contributing
for CKD. The underlying mechanisms deserve further
investigation. Strategies aimed at intervention of hyperten-
sion and other metabolic disorders might prove effective
in controlling the pandemic of CKD in family members of
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